Clinical Trial testing TH-302 in combination with gemcitabine in combination in previously untreated patients with pancreatic cancer

Update Il y a 4 ans
Reference: EUCTR2012-002957-42

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the trial is to evaluate efficacy, as measured by overall survival (OS), of gemcitabine in combination with TH-302 compared to gemcitabine in combination with placebo in subjects with previously untreated locally advanced unresectable or metastatic pancreatic adenocarcinoma.


Inclusion criteria

  • Locally advanced unresectable pancreatic adenocarcinoma